Temporal association between antibiotic use and resistance in Gram-negative bacteria

Abstract

The β-lactam/lactamase inhibitors (BLBLIs) combination drugs are considered an effective alternative to carbapenems. However, there is a growing concern that the increased use of BLBLIs may lead to increased resistance. This study determined the temporal association between the consumption of BLBLI and the antimicrobial resistance in Gram-negative bacteria. In this retrospective study, electronic data on the Gram-negative bacterial isolates, including A. baumannii, P. aeruginosa, E. coli, and K. pneumoniae from in-patients and susceptibility testing results were retrieved from the medical records of the clinical laboratory. A linear regression and cross-correlation analysis were performed on the acquired data. Increasing trends (p<0.05) in the consumption of BIBLI and carbapenem with a median use of 27.68 and 34.46 DDD/1000 PD per quarter were observed, respectively. A decreased trend (p=0.023) in the consumption of fluoroquinolones with a median use of 29.13 DDD/1000 PD per quarter was observed. The resistance rate of K. pneumoniae was synchronized with the BIBLI and carbapenem consumptions with a correlation coefficient of 0.893 (p=0.012) and 0.951 (p=0.016), respectively. The cross-correlation analysis against the consumption of BIBLI and meropenem resistant K. pneumoniae was peaked at 0-quarter lag (r=951, p=0.016). There was an increasing trend in the consumption of BLBLI and carbapenems. The increasing trend in the rates of resistance to piperacillin/tazobactam, in line with the increasing consumption of BLBLI, suggests that BLBLI has to be used with caution and cannot be directly considered as a long-term alternative to carbapenems.

Colonization by Streptococcus pneumoniae among children in Porto Velho, Rondônia, Western Brazilian Amazon

“…The hospital environment has high rates of antimicrobial resistance due to the large handling of hospital antimicrobials in these places, causing a global health problem with estimates of thousands of deaths in the next years (Wu et al, 2021;Melo et al, 2021). In 2017, S. pneumoniae joined the list of 12 priority pathogenic bacteria that was released by the World Health Organization due to of the increase in the rate of infections and resistance to antimicrobials (WHO, 2017).…”

Dynamics of antibiotics and antibiotic resistance genes in four types of kitchen waste composting processes

“…Las anteriores definiciones indican que un microorganismo, además de ser resistente a un antibiótico y a los integrantes de la misma familia antibiótica, puede ser resistente a otras familias de antibióticos o en el peor de los casos no ser sensible a ningún antibiótico de ninguna categoría (Gómez Ayerbe et al, 2016;Ruiz y Cantón, 2016). En literatura ya se 10 Desarrollo de una herramienta de cultivo continuo para la generación de mutantes inducidos por exposición a agentes antibacterianos han descrito previamente varios casos de este estilo, en los que microorganismos inicialmente resistentes a un agente antibacteriano han terminado mostrando resistencia frente a antibióticos de otras familias (Rincón et al, 2014;Rossi et al, 2014;Wua et al, 2021), lo que lleva a un estado de alarma muy grande frente a la pérdida de alternativas terapéuticas que puedan dar respuesta a cuadros clínicos que se presenten con este tipo de microorganismos (Fariñas y Martínez, 2013;Obolski et al, 2016;Rayner y Munckhof, 2005).…”